Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions

Status:
Completed

Trial end date:
2015-05-01

Target enrollment:

Participant gender:

This trial investigates the effects of FE 200440 compared to placebo on implantation rate in women undergoing IVF/ICSI treatment

Phase 2

Ferring Pharmaceuticals